Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Description

The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD). This study is testing the health of the blood vessels and the activity of the nerves that control the blood vessels in adults with insulin resistance. The extent to which ascorbic acid (Vitamin C) improves the function of the blood vessels will be determined. The primary outcome is blood pressure, which is the result of blood vessel health and activity of the nerves, and the reduction in blood pressure that is observed with ascorbic acid.

Conditions

Hypertension, Cardiovascular Diseases

Talk to us

Study Overview

On this page

Study Details

Study overview

The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence of hypertension and risk for cardiovascular disease (CVD). This study is testing the health of the blood vessels and the activity of the nerves that control the blood vessels in adults with insulin resistance. The extent to which ascorbic acid (Vitamin C) improves the function of the blood vessels will be determined. The primary outcome is blood pressure, which is the result of blood vessel health and activity of the nerves, and the reduction in blood pressure that is observed with ascorbic acid.

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Condition
Hypertension
Intervention / Treatment

-

Contacts and Locations

Kansas City

University of Kansas Medical Center, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Obese: BMI \>30 m/kg2
  • 2. Middle-aged: 35-65 years
  • 3. Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior.
  • 4. Able and willing to provide written informed consent
  • 1. Diabetes mellitus: fasting glucose \< 1267 mg/dL and/or HbA1c \< 6.5%
  • 2. Currently taking a statin or antihypertension medication
  • 3. Hyperlipidemia: Fasting triglycerides \< 250 mg/dL
  • 4. Hypertension: \<130/80 mmHg
  • 5. History of heart disease (e.g., myocardial infarction, stent)
  • 6. History of vascular disease (e.g., bypass, stroke)

Ages Eligible for Study

35 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Seth Holwerda, PhD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2025-04-01